Table: Noile-Immune Biotech - Q1 parent results

Noile-Immune Biotech

12/05/2025 08:30

May 12 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2025        Mar 31, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2 mln               2 mln                     
                 (-17.2 pct)         (-68.0 pct)                  
  Operating     loss 241 mln        loss 339 mln                  
  Recurring     loss 239 mln        loss 339 mln                  
  Net           loss 240 mln        loss 340 mln                  
  EPS           loss 5.55 yen       loss 7.86 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T